10-Q: Maquia Capital Acquisition Corp. Reports Mixed Q2 Results Amidst Delisting Concerns and Business Combination Efforts

Maquia Capital Acquisition Corporation reported a net income of $969,441 for the second quarter of 2024, while facing delisting from Nasdaq and pursuing a new business combination.

Summary

• Maquia Capital Acquisition Corporation reported a net income of $969,441 for the three months ended June 30, 2024, compared to a net loss of $367,435 for the same period in 2023.
• The company's net income for the six months ended June 30, 2024, was $806,483, a significant improvement from the net loss of $89,175 reported for the same period in 2023.
• The increase in net income was primarily driven by unrealized gains on investments, changes in the fair value of derivative liabilities, and a tax benefit.
• General and administrative expenses were $442,336 for the three months ended June 30, 2024, and $680,314 for the six months ended June 30, 2024.
• The company's cash and cash equivalents stood at $2,560 as of June 30, 2024, with a working capital deficiency of $3,726,156.
• Maquia has been facing challenges with Nasdaq listing compliance, including a delisting notice due to failure to complete a business combination within the required timeframe.
• The company has entered into a new business combination agreement with Velocium, Inc. after terminating a previous agreement with Immersed, Inc.
• Stockholders approved an extension to complete a business combination until January 7, 2025, with 861,653 shares redeemed in connection with the vote.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with some positive financial results but significant negative factors such as delisting concerns, low cash, and internal control weaknesses. The overall sentiment is negative due to the high risk of liquidation and the company's struggles with Nasdaq compliance.

Positives

• The company achieved a net income of $969,441 for the three months ended June 30, 2024, a significant improvement compared to the net loss of $367,435 in the same period last year.
• The company's net income for the first six months of 2024 was $806,483, a substantial increase from the net loss of $89,175 for the same period in 2023.
• The company has secured a new business combination agreement with Velocium, Inc., indicating progress in its search for a target company.
• Stockholders have approved an extension to complete a business combination until January 7, 2025, providing additional time to finalize a deal.

Negatives

• The company's cash and cash equivalents are very low at $2,560 as of June 30, 2024, and it has a working capital deficiency of $3,726,156.
• Maquia has received a delisting notice from Nasdaq due to failure to complete a business combination within the required timeframe.
• The company terminated a previous business combination agreement with Immersed, Inc., incurring costs and delays.
• The company has experienced material weaknesses in internal controls over financial reporting, specifically in areas of complex financial instruments, income taxes, and trust account management.

Risks

• The company faces significant risk of delisting from Nasdaq due to its failure to complete a business combination within the required timeframe.
• The company's low cash balance and working capital deficiency raise concerns about its ability to fund operations and complete a business combination.
• There is a risk that the company may not be able to complete a business combination by the extended deadline of January 7, 2025, leading to liquidation.
• The company's internal control weaknesses could lead to material misstatements in financial reporting.
• The company is subject to the risk of economic downturns and market volatility, which could impact its ability to complete a business combination.
• The company is subject to a 1% excise tax on share repurchases and a 15% corporate alternative minimum tax, which could impact its financial results.

Future Outlook

The company is focused on completing a business combination by January 7, 2025, and is working to address its Nasdaq listing compliance issues. The company is also evaluating its options with respect to payment of the excise tax obligation.

Management Comments

• Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company's financial position, results of its operations, close of the Proposed Public Offering and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements.
• Management is currently evaluating the impact of the Inflation Reduction Act (IR Act) and its provisions imposing a 1% excise tax on share repurchases and a 15% corporate alternative minimum tax (CAMT).
• Management believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate.

Industry Context

The document reflects the challenges faced by many SPACs in the current market, including difficulties in finding suitable merger targets and maintaining listing compliance. The company's struggles with Nasdaq and the need for multiple extensions highlight the competitive and challenging environment for SPACs.

Comparison to Industry Standards

• The company's financial performance is mixed, with a significant improvement in net income compared to the previous year, but a very low cash balance and a working capital deficiency.
• The company's struggles with Nasdaq listing compliance are not uncommon among SPACs, but the delisting notice is a serious concern.
• The company's multiple extensions to complete a business combination are also not unusual, but the limited time remaining and the delisting notice put the company in a difficult position.
• The company's internal control weaknesses are a concern and need to be addressed to ensure accurate financial reporting.
• Compared to other SPACs, Maquia's situation is more precarious due to the delisting notice and the very low cash balance. Many SPACs have been forced to liquidate due to similar issues.

Related Party Transactions

• The Sponsor has provided loans to the company to fund operations and extensions.
• The Sponsor has agreed to transfer shares to third parties in exchange for non-redemption agreements.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company is unable to complete a business combination and is liquidated.
• Employees may face uncertainty about their future employment if the company is liquidated.
• Creditors may face the risk of not being repaid if the company is liquidated.
• The company's delisting from Nasdaq could negatively impact the value of its securities.

Next Steps

• The company needs to complete a business combination by January 7, 2025.
• The company needs to address its Nasdaq listing compliance issues.
• The company needs to address its internal control weaknesses.
• The company needs to evaluate its options with respect to payment of the excise tax obligation.

Key Dates

Keywords

SPAC, Business Combination, Delisting, Nasdaq, Financial Results, Merger, Acquisition, Warrants, Redemption, Trust Account